Your browser doesn't support javascript.
loading
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.
de Billy, Emmanuel; Pellegrino, Marsha; Orlando, Domenico; Pericoli, Giulia; Ferretti, Roberta; Businaro, Pietro; Ajmone-Cat, Maria Antonietta; Rossi, Sabrina; Petrilli, Lucia Lisa; Maestro, Nicola; Diomedi-Camassei, Francesca; Pezzullo, Marco; De Stefanis, Cristiano; Bencivenga, Paola; Palma, Alessia; Rota, Rossella; Del Bufalo, Francesca; Massimi, Luca; Weber, Gerrit; Jones, Chris; Carai, Andrea; Caruso, Simona; De Angelis, Biagio; Caruana, Ignazio; Quintarelli, Concetta; Mastronuzzi, Angela; Locatelli, Franco; Vinci, Maria.
Afiliação
  • de Billy E; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Pellegrino M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Orlando D; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Pericoli G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Ferretti R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Businaro P; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Ajmone-Cat MA; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità-Rome, Rome, Italy.
  • Rossi S; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Petrilli LL; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Maestro N; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Diomedi-Camassei F; Department of Laboratories-Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Pezzullo M; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • De Stefanis C; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Bencivenga P; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Palma A; Research Laboratories, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Rota R; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Del Bufalo F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Massimi L; Department of Pediatric Neurosurgery, Catholic University Medical School, Rome, Italy.
  • Weber G; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Jones C; Division of Molecular Pathology, Institute of Cancer Research, Sutton, UK.
  • Carai A; Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Caruso S; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • De Angelis B; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Caruana I; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Quintarelli C; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Mastronuzzi A; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Locatelli F; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
  • Vinci M; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
Neuro Oncol ; 24(7): 1150-1163, 2022 07 01.
Article em En | MEDLINE | ID: mdl-34964902

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Insulina / Imunoterapia Adotiva / Receptor IGF Tipo 1 / Neoplasias do Tronco Encefálico / Glioma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Insulina / Imunoterapia Adotiva / Receptor IGF Tipo 1 / Neoplasias do Tronco Encefálico / Glioma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália